The major drug market drivers are rising incomes, easier access to high-quality healthcare facilities, and greater awareness of personal health and hygiene.
By
Avishek Majumder and Priya Chetty on May 7, 2019 No Comments
Indian pharmaceutical market predominately comprises of generic drugs (70% revenue share) with lesser OTC drugs (21% revenue share) and a very few patented drugs (9% revenue share).
By
Avishek Majumder and Priya Chetty on April 25, 2019 No Comments
In the global pharmaceutical marketplace, the Indian pharmaceutical industry is at 13th position, in terms of value and has the 3rd largest volume (Department of Commerce, 2017).
By
Avishek Majumder and Abhinash Jena on April 8, 2019 No Comments
The Drug Price Control Order (DPCO) was enacted by the Government of India in 1955. The latest amendments to the policy and regulations were made in 2013 and termed as DCPO-2013 (National Pharmaceutical Pricing Authority, 2018).
By
Avishek Majumder and Priya Chetty on March 28, 2019 No Comments
Federal Food, Drug, and Cosmetic Act (FFDCA) of the United States were enacted to prevent the adulteration of food and drugs and their misbranding (Wozniak et al., 2012).
By
Avishek Majumder and Abhinash Jena on March 22, 2019 No Comments
The pharmaceutical drug market comprises of expenditures, value generation, sales, production capabilities, and availability. However, the drug market is mainly determined by the sales or the production rate of the companies.
We are a team of dedicated analysts that have competent experience in data modelling, statistical tests, hypothesis testing, predictive analysis and interpretation.